At CiplaQCIL, we stand by our motto that everyone should have access to lifesaving medication. In the crusade against HIV, CiplaQCIL has manufactured medication that has revolutionized HIV treatment, changing it from something which was previously considered a death sentence, to something which can be managed like any other chronic condition.
HIV / Aids
None shall be denied
In 2001, Cipla introduced the world’s first ever recommended 3-in-1 fixed dose combination (Stavudine + Lamivudine + Nevirapine) to fight AIDS. It was made available at less than $1 per day compared to over $12,000 per patient per year prevailing in Uganda and most countries around the world.
Cipla has developed medication that has revolutionised HIV therapy, and as a result, people living with HIV can have a normal life if they adhere to their treatment. We’re also focused on educating people about the importance of knowing their status, and also ending stigma around HIV/AIDS.
#CaringForLife #EndStigma #KnowYourStatus
Lamivudine, Zidovudine & Nevirapine Tablets 150mg / 300mg / 200mg
Lamivudine and Zidovudine Tablets 150mg / 300 mg
Efavirenz Tablets 600 mg
Lamivudine and Tenofovir Disoproxil Fumarate Tablets 300 mg / 300 mg
Nevirapine Tablets 200 mg
Efavirenz, Lamivudine & Tenofovir Disoproxil Fumarate Tablets 600 mg / 300 mg / 300 mg
Dolutegravir (as Sodium), Lamivudine & Tenofovir Disoproxil Fumarate 50 mg / 300 mg / 300 mg Tablets